Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 10, 2014, Pages 3873-3878

  Ohya, Masaki ^a   Negi, Shigeo ^a   Sakaguchi, Toshifumi ^a   Koiwa, Fumihiko ^b   Ando, Ryoichi ^b   Komatsu, Yasuhiro ^b   Shinoda, Toshio ^b   Inaguma, Daijo ^b   Joki, Nobuhiko ^b   Yamaka, Toshihiko ^b   Ikeda, Masato ^b   Shigematsu, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Japan Study Group of Assessing Initiation of Renal Replacement Therapy   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIANEMIC AGENT; MAGNESIUM; PARATHYROID HORMONE; RENIN INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; HEALTH CARE FACILITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HORMONAL REGULATION; HUMAN; HYPERMAGNESEMIA; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; UREMIA; BLOOD; GLOMERULUS FILTRATION RATE; METABOLIC DISORDER; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MAGNESIUM; MALE; METABOLIC DISEASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; UREMIA; YOUNG ADULT;

EID: 84907612125     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4396     Document Type: Article

References (28)

1. Naveh-Many T, Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest. 1990;86:1313-1319.
2. Brown EM, Pollak M, Seidman CE, et al. Calcium-ion-sensing cellsurface receptors. N Engl J Med. 1995;333:234-240.
3. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8-F28.
4. Silver J, Naveh-Many T. Phosphate and the parathyroid. Kidney Int. 2009;75:898-905.
5. Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant. 2013;28:869-878.
6. Salem S, Bruck H, Bahlmann FH, et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol. 2012;35:31-39.
7. Brown EM. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev. 1991;71:371-411.
8. Navarro JF, Mora C, Jimenez A, Torres A, Macia M, Garcia J. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis. 1999;34:43-48.
9. Navarro JF, Mora C, Macia M, Garcia J. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Perit Dial Int. 1999;19:455-461.
10. Gohda T, Shou I, Fukui M, et al. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients. Am J Kidney Dis. 2002;39:1255-1260.
11. Coburn JW, Popovtzer MM, Massry SG, Kleeman CR. The physicochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med. 1969;124:302-311.
12. Nilsson P, Johansson SG, Danielson BG. Magnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium. Nephron. 1984;34:25-29.
13. Katopodis KP, Koliousi EL, Andrikos EK, Pappas MV, Elisaf MS, Siamopoulos KC. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration. Artif Organs. 2003;27:853-857.
14. Ejaz AA, McShane AP, Gandhi VC, Leehey DJ, Ing TS. Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution. Perit Dial Int. 1995;15:61-64.
15. Kelber J, Slatopolsky E, Delmez JA. Acute effects of different concentrations of dialysate magnesium during high-efficiency dialysis. Am I Kidney Dis. 1994;24:453-460.
16. Navarro JF, Mora C, Garcia J. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial. 2009;22:37-44.
17. Dewitte K, Dhondt A, Giri M, et al. Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study. Diabetes Care. 2004;27:2503-2505.
18. Koiwa F, Komukai D, Hirose M, et al. Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients. Clin Exp Nephrol. 2012;16:130-135.
19. Azar Baradarn, Hamid Nasri. Correlation of serum magnesium with serum parahormone levels in patients on regular hemodialysis. Saudi J Kidney Dis Transplant. 2006;17:344-350.
20. Saha HT, Harmoinen AP, Pasternack AI. Measurement of serum ionized magnesium in CAPD patients. Perit Dial Int. 1997;17:347-352.
21. Irazuzta J, Egelund T, Wassil SK, Hampp C. Feasibility of shortterm infusion of magnesium sulfate in pediatric patients with status asthmaticus. J Pediatr Pharmacol Ther. 2012;17:150-154.
22. Lircelli F, Peter ME, Celenk FG, et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant. 2012;27:514-521.
23. Rodríguez-Ortiz ME, Canalejo A, Herencia C, et al. Magnesium modulates parathyroid hormone section and upregulates parathyroid receptor expression at moderately low calcium concentration. Nephrol Dial Transplant. 2014;29:282-289.
24. Tzanakis I, Pras A, Kounalii D, et al. Mitral annular calcification in haemodialysis patients: possible protective roles of magnesium. Nephrol Dial Transplant. 1997;12:2036-2037.
25. Tzanakis I, Virvidakis K, Tsomi A, et al. Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res. 2004;17:102-108.
26. Turgot F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol. 2008;40:1075-1082.
27. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res. 2007;20:237-244.
28. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and noncardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2013;85:174-181.